My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Ocugen, Inc. - Common Stock (NQ:OCGN)

1.190 -0.050 (-4.03%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

35 36 Next >

23 Stocks Moving in Wednesday's Pre-Market Session ↗

February 23, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) rose 64.9% to $2.54 in pre-market trading after gaining around 5% on Tuesday. Roth Capital recently initiated coverage on the...

Via Benzinga

73 Biggest Movers From Yesterday ↗

February 23, 2022

Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE...

Via Benzinga

OCGN Stock Alert: Why Is Ocugen Heating Up Today? ↗

February 22, 2022

Shares of OCGN stock are flying higher after the FDA lifted its clinical hold on Covaxin, the company's coronavirus drug candidate.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 22, 2022

Gainers Revelation Biosciences (NASDAQ:REVB

Via Benzinga

Ocugen Is Too Uncertain as Time Runs Out for Covaxin’s Approval ↗

February 22, 2022

Ocugen's path to entry in the North American market is highly uncertain, making OCGN stock a remarkably risky bet at this point.

Via InvestorPlace

Mid-Afternoon Market Update: US Stocks Pare Losses; Meritor Shares Spike Higher ↗

February 22, 2022

U.S. stocks pared back some losses toward the end of trading on Tuesday. Russian President Vladimir Putin said he would recognize the independence of two Russian-led...

Via Benzinga

Production Updates Could Give Novavax Stock a Big Boost ↗

February 22, 2022

Given the low expectations for Novavax's deliveries, better-than-expected numbers could send the NVAX stock price back to the triple digits.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 22, 2022

Gainers Ocugen (NASDAQ:OCGN) stock rose 25.0% to $4.33 during Tuesday's regular session. As of 12:30 EST, Ocugen's stock is trading at a volume of 42.0 million,...

Via Benzinga

Despite an 80% Drop, Ocugen Stock Is Still Too Pricey ↗

February 21, 2022

Until the hype surrounding its Covid-19 vaccine candidate is no longer priced into shares, it's best to avoid OCGN stock.

Via InvestorPlace

Ocugen To Buy Liminal's Dormant Vaccine Manufacturing Plant In Canada ↗

January 27, 2022

Ocugen Inc (NASDAQ: OCGN) has

Via Benzinga

50 Stocks Moving In Tuesday's Mid-Day Session ↗

February 22, 2022

Gainers Indonesia Energy Corporation Limited (NYSE: INDO) jumped 75.2% to $7.87. Imperial Petroleum Inc. (NASDAQ: IMPP) rose 52.9% to $0.7500 after declining around 7% on Friday...

Via Benzinga

Mid-Day Market Update: Stocks Extend Losses; Dow Tumbles Over 400 Points ↗

February 22, 2022

U.S. stocks extended its earlier losses midway through trading on Tuesday, amid rising tensions between Russia and Ukraine. Russian President Vladimir Putin said he would...

Via Benzinga

Dow Drops Triple Digits as Investors Eye Sanctions ↗

February 22, 2022

The Dow Jones Industrial Average is down 292 points midday. The S&P 500 Index and Nasdaq Composite are sharply lower as well, as the major indexes begin their holiday-shortened week after their...

Via Talk Markets

Dear AMC Stock Fans, Mark Your Calendars for March 1 ↗

February 22, 2022

Investors in AMC Entertainment (AMC) stock are going to want to keep an eye on the movie theater company when March 1 rolls around.

Via InvestorPlace

Chinese Stocks Alert: Why Are BABA, TCEHY, JD, PDD Stocks Down Today? ↗

February 22, 2022

Chinese tech stocks are taking a beating on Tuesday as investors worry about additional restrictions from the country's government.

Via InvestorPlace

Why Ocugen Shares Are Rising ↗

February 22, 2022

Ocugen Inc (NASDAQ: OCGN) shares are trading higher by 23.8% at $4.28 Tuesday morning after the company announced the FDA lifted its clinical hold on the company's COVID-19 vaccine study in the US.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 22, 2022

Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 15.5% to $3.95 during Tuesday's pre-market session. The company's market cap stands at $213.3 million....

Via Benzinga

FDA Lifts Clinical Hold On Ocugen's COVID-19 Vaccine Study In US ↗

February 22, 2022

The FDA has lifted its clinical hold on Ocugen Inc's (NASDAQ: OCGN) investigational new drug application seeking approval to conduct testing of the COVID-...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

February 22, 2022

With the long weekend over it's time to start another week of trading with the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

30 Stocks Moving in Tuesday's Pre-Market Session ↗

February 22, 2022

Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) rose 28.5% to $108.31 in pre-market trading. Just hours after launching on Sunday night in Apple’s App Store, Donald...

Via Benzinga

Ocugen Stock Finally Sunk to Penny Status, But That Doesn’t Make It a Buy ↗

February 21, 2022

An interview with Dr. Anthony Fauci about the Covaxin vaccine makes you wonder why investors have any interest in OCGN stock.

Via InvestorPlace

Americans’ Appetite for Vaccine Options Bodes Well for Ocugen ↗

February 21, 2022

OCGN stock is definitely out of favor on Wall Street, but fresh poll data and an imminent R&D hub acquisition should spur some optimism.

Via InvestorPlace

Ocugen Stock Is a Fairy Tale in Need of a Happy Ending ↗

February 18, 2022

If you’re investing in OCGN stock, you have to wonder: how much upside can FDA approval really give this beleaguered name?

Via InvestorPlace

Novavax Stock Is at Risk Despite Positive Poll Results ↗

February 16, 2022

A recent poll supports Novavax's Covid treatment in the United States, but the vote on today's NVAX stock price chart warns against buying.

Via InvestorPlace

Who's Winning - The 'Shorters' Or The 'Squeezers'? ↗

February 14, 2022

A look at how well the 'squeezers' are doing relative to the

Via Talk Markets

Two Reasons to Skip Ocugen Stock Despite Some Good News ↗

February 09, 2022

Ocugen was one of the most explosive stocks on the market, all thanks to its coronavirus vaccine, Covaxin. But don't rush to buy just yet.

Via InvestorPlace

With No Vaccine Approval, Ocugen Is the Definition of Dead Money ↗

February 09, 2022

Holding out hope for a Covid vaccine approval that might never come, OCGN stock is too risky while the company has no revenue.

Via InvestorPlace

3 Biotech Stocks That Could Boom or Bust in Q1 ↗

February 01, 2022

The biotech industry is exploding. Biotech stocks provide lots of opportunities for investors who are taking a risk on the medicine's future.

Via InvestorPlace

Despite Big Disappointment, There’s Still Potential With Ocugen Stock ↗

January 25, 2022

As this biotech's stock continues to slide lower in price, risk-tolerant investors may find an opportunity with beaten down OCGN stock.

Via InvestorPlace

20 Stocks Moving in Tuesday's Pre-Market Session ↗

January 25, 2022

Gainers Aptorum Group Limited (NASDAQ: APM) shares rose 94.4% to $3.15 in pre-market trading after gaining around 10% on Monday. The FDA recently granted Orphan Drug Designation...

Via Benzinga

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.